Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Blood

Volumn 118, Issue 20, 2011, Pages 5604-5612

  Kornblau, Steven M ^a   Qiu, Yi Hua ^a   Zhang, Nianxiang ^a   Singh, Neera ^a   Faderl, Stefan ^a   Ferrajoli, Alessandra ^a   York, Heather ^b   Qutub, Amina A ^b   Coombes, Kevin R ^a   Watson, Dennis K ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Rice University   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR FLI 1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD; CELL PROLIFERATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

EID: 81555228391     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-348052     Document Type: Article

References (53)

1. Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci U S A. 1990;87(4):1332-1336.
2. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5(6):908-918. (Pubitemid 21906006)
3. Mélet F, Motro B, Rossi DJ, Zhang L, Bernstein A. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol. 1996;16(6):2708-2718. (Pubitemid 26161274)
4. Maroulakou IG, Bowe DB. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene. 2000;19(55):6432-6442. (Pubitemid 32108433)
5. Truong AH, Ben-David Y. The role of Fli-1 in normal cell function and malignant transformation. Oncogene. 2000;19(55):6482-6489. (Pubitemid 32108438)
6. Watson DK, Smyth FE, Thompson DM, et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 1992;3(10):705-713.
7. Spyropoulos DD, Pharr PN, Lavenburg KR, et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol. 2000;20(15):5643-5652. (Pubitemid 30482898)
8. Kawada H, Ito T, Pharr PN, et al. Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int J Hematol. 2001;73(4):463-468. (Pubitemid 33758879)
9. Hart A, Melet F, Grossfeld P, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000;13(2):167-177.
10. Masuya M, Moussa O, Abe T, et al. Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood. 2005;105(1):95-102. (Pubitemid 40053069)
11. Zhang XK, Moussa O, LaRue A, et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008;181(3):1644-1654.
12. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005;41(16):2462-2478. (Pubitemid 41540623)
13. Watson DK, Turner DP, Scheiber MN, Findlay VJ, Watson PM. ETS Transcription factor expression and conversion during prostate and breast cancer progression. Open Cancer J. 2010;3:24-39.
14. Torlakovic EE, Slipicevic A, Florenes VA, et al. Fli-1 expression in malignant melanoma. Histol Histopathol. 2008;23(11):1309-1314.
15. Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem. 2004;279(12):11281- 11292. (Pubitemid 38401625)
16. He J, Pan Y, Hu J, et al. Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther. 2007;6(1):76-82. (Pubitemid 46294180)
17. Sakurai T, Kondoh N, Arai M, et al. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci. 2007;98(11):1775-1784. (Pubitemid 47487915)
18. Zhang J, Guo H, Zhang H, et al. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer. 2011;117(1):86-95.
19. Crossen PE, Morrison MJ, Rodley P, Cochrane J, Morris CM. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet. 1999;113(2):126-133. (Pubitemid 29381548)
20. Tyybäkinoja A, Saarinen-Pihkala U, Elonen E, Knuutila S. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer. 2006;45(3):257-264. (Pubitemid 43238476)
21. Savli H, Sirma S, Ozbek U. Quantification of the FLI1 gene expression by real-time quantitative RT-PCR. Turkish J Med Sci. 2003;33:21-25. (Pubitemid 36193751)
22. Dhulipala PD, Lee L, Rao VN, Reddy ES. Fli-1b is generated by usage of differential splicing and alternative promoter. Oncogene. 1998;17(9):1149-1157. (Pubitemid 28444599)
23. Bock O, Hussein K, Neusch M, et al. Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation. Eur J Haematol. 2006;77(6):463-470. (Pubitemid 44690791)
24. Poppe B, Vandesompele J, Schoch C, et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood. 2004;103(1):229-235. (Pubitemid 38029943)
25. Seth A, Giunta S, Franceschil C, Kola I, Venanzoni MC. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products. Cell Death Differ. 1999;6(9):902-907. (Pubitemid 29488088)
26. Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene. 1999;18(54):7755-7764. (Pubitemid 30052760)
27. Lesault I, Quang CT, Frampton J, Ghysdael J. Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1-transformed erythroblasts. EMBO J. 2002;21(4):694-703. (Pubitemid 34174050)
28. Seth A, Robinson L, Thompson DM, Watson DK, Papas TS. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene. 1993;8(7):1783-1790. (Pubitemid 23212410)
29. Tamir A, Howard J, Higgins RR, et al. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol. 1999;19(6):4452-4464. (Pubitemid 29242019)
30. Truong AH, Cervi D, Lee J, Ben-David Y. Direct transcriptional regulation of MDM2 by Fli-1. Oncogene. 2005;24(6):962-969. (Pubitemid 40313873)
31. Lakhanpal GK, Vecchiarelli-Federico LM, Li YJ, et al. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood. 2010;116(3):428-436.
32. Tibes R, Qiu YH, Lu Y, et al. Reverse phase protein array (RPPA): validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoetic stem cells (HSC). Mol Cancer Ther. 2006;5(10):2512-2521. (Pubitemid 44650915)
33. Kornblau SM, Singh N, Qiu YH, et al. Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia [abstract]. Blood. 2009;114:166-167.
34. Kornblau SM, Tibes R, Qiu YH, et al. Functional proteomic profiling of AML predicts response and survival. Blood. 2009;113(1):154-164.
35. Hunyady B, Krempels K, Harta G, Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem. 1996;44(12):1353-1362.
36. Hu J, He X, Baggerly KA, et al. Non-parametric quantification of protein lysate arrays. Bioinformatics. 2007;23(15):1986-1994. (Pubitemid 47299840)
37. Neeley ES, Kornblau SM, Coombes KR, Baggerly KA. Variable slope normalization of reverse phase protein arrays. Bioinformatics. 2009;25(11):1384-1389.
38. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res. 2003;31(1):248-250. (Pubitemid 36150376)
39. Gilbert D. Biomolecular interaction network database. Brief Bioinform. 2005;6(2):194-198. (Pubitemid 40872285)
40. Baxevanis AD. The importance of biological databases in biological discovery. Curr Protoc Bioinformatics. 2006;Chapter 1:Unit 1.1.
41. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504. (Pubitemid 37428274)
42. Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene. 2000;19(55):6533-6548. (Pubitemid 32108443)
43. ZhangW, Kornblau SM, Kobayashi T, et al. High levels of constitutiveWAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res. 1995;1(9):1051-1057.
44. Liu F, Walmsley M, Rodaway A, Patient R. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol. 2008;18(16):1234-1240.
45. Asano Y, Trojanowska M. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta. Mol Cell Biol. 2009;29(7):1882-1894.
46. Sevilla L, Zaldumbide A, Carlotti F, et al. Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU. 1. J Biol Chem. 2001;276(21):17800-17807.
47. Nakazawa Y, Suzuki M, Manabe N, et al. Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression. Oncogene. 2007;26(24):3541-3550. (Pubitemid 46816758)
48. Oda N, Abe M, Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol. 1999;178(2):121-132. (Pubitemid 29034855)
49. Pearse DD, Tian RX, Nigro J, et al. Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am J Physiol Renal Physiol. 2008;294(5):F1094-F1100.
50. Mamali I, Kotsantis P, Lampropoulou M, Marmaras VJ. Elk-1 associates with FAK, regulates the expression of FAK and MAP kinases as well as apoptosis in HK-2 cells. J Cell Physiol. 2008;216(1):198-206. (Pubitemid 351813111)
51. Ikeda S, Mochizuki A, Sarker AH, Seki S. Identification of functional elements in the bidirectional promoter of the mouse Nthl1 and Tsc2 genes. Biochem Biophys Res Commun. 2000;273(3): 1063-1068. (Pubitemid 30481079)
52. Hodge DR, Li D, Qi SM, Farrar WL. IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. Biochem Biophys Res Commun. 2002;292(1):287-291. (Pubitemid 34687362)
53. Pereira R, Quang CT, Lesault I, et al. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene. 1999;18(8):1597-1608. (Pubitemid 29108060)